ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan
· Delayed Price · Currency is TWD 79.50
+2.20 (2.85%)
Aug 15, 2025, 1:59 PM CST
ACRO Biomedical Revenue
In the year 2024, ACRO Biomedical had annual revenue of 44.23M TWD, down -13.38%. ACRO Biomedical had revenue of 23.19M in the half year ending December 31, 2024, with 89.69% growth.
Revenue
44.23M
Revenue Growth
-13.38%
P/S Ratio
108.78
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.81B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Lumosa Therapeutics | 37.25M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |